Impact of Omega-3 Fatty Acids on Cardiovascular Disease Prevention: an updated Meta-analysis of RCTs
Abstract
Background: Omega-3 fatty acids have been extensively studied for their potential role in cardiovascular disease (CVD) prevention. This meta-analysis aims to provide an updated synthesis of data from randomized controlled trials (RCTs) to assess the efficacy of omega-3 supplementation in reducing cardiovascular risk.
Methods: We conducted a meta-analysis of 17 RCTs involving 82,592 patients. The primary outcomes assessed were changes in triglyceride and LDL cholesterol levels, the incidence of major cardiovascular events (MACE), and cardiac mortalities. Statistical analyses were performed using a random-effects model.
Results: Omega-3 supplementation resulted in a significant reduction in triglyceride levels by an average of 4.41 mg/dL (95% CI: -10.16 to 1.88) and a modest decrease in LDL levels by 0.70 mg/dL (95% CI: -2.12 to 0.72). Additionally, omega-3 fatty acids were associated with a 10% reduction in the risk of major cardiovascular events (RR: 0.90, 95% CI: 0.82 to 0.99) and a 35% reduction in cardiac mortalities (RR: 0.65, 95% CI: 0.44 to 0.95).
Conclusion: This meta-analysis supports the use of omega-3 fatty acids as a preventive strategy in cardiovascular care, demonstrating significant benefits in lowering triglyceride levels, reducing major cardiovascular events, and decreasing cardiac mortalities.
How strong is the evidence?
Evidence Hub reads this as a meta-analysis, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 82,592 participants or records.
Read the paper
Related studies
- eggNOG 5.0: a hierarchical, functionally and phylogenetically annotated orthology resource based on 5090 organisms and 2502 viruses
- Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
- OptiType: precision HLA typing from next-generation sequencing data
- Nicotinic Cholinergic System and COVID-19: In Silico Identification of an Interaction between SARS-CoV-2 and Nicotinic Receptors with Potential Therapeutic Targeting Implications
- Saccharomyces cerevisiae cells have three Omega class glutathione S-transferases acting as 1-Cys thiol transferases
- Hemolysis at low blood flow rates: in-vitro and in-silico evaluation of a centrifugal blood pump
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.